Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
ADCY7 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADCY7, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADCY4 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADCY4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADCK5 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADCK5, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADCK2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADCK2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADCK1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADCK1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAT3 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAT3, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAT2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAT2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAT1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAT1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADARB2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADARB2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADARB1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADARB1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAR Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAR, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAP2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAP2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.